| Metric | Value | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 272.36 Cr | 2.5% | 9.6% |
| Total Income | 272.74 Cr | 2.2% | 9.2% |
| Expenditure | 271.22 Cr | 4.1% | 12.1% |
| PBT | 1.53 Cr | 70.3% | 80.9% |
| Net Profit | 1.14 Cr | 84.8% | 85.7% |
| OPM | 3.11% | 1.48pp | 2.36pp |
| NPM | 0.42% | 2.39pp | 2.77pp |
| EPS | 0.03 | 80.0% | 96.0% |
Revenue resilience masks unproven profit recovery
Sumeet reported 9.6% revenue growth but profits collapsed 85.7%, with gross margins crashing from 25%+ to 15%. The quarter's biggest story — inventory liquidation hiding a 17% volume decline — raises red flags about underlying demand and the credibility of FY27 guidance.
₹1.1 Cr
-85.7% YoY
~15%
vs 25%+ prior
-17% QoQ
revenue held via inventory liquidation
Sumeet delivered ₹272.4 Cr revenue (+9.6% YoY), but here's the problem: profits crashed to ₹1.1 Cr from ₹7+ Cr a year ago, and the company maintained sales despite a 17% drop in production volumes. One of those facts doesn't belong with the other two. The quarter is best understood as a test of margin recovery that failed, and inventory liquidation that masked the failure.
Where the margin went — and why the cost story matters
Gross margins fell from 25%+ in prior quarters to ~15% in Q1. Management blamed crude oil volatility and freight cost spikes — PTA and MEG (polyester feedstocks) swung sharply due to geopolitical tensions in the Middle East and US — and attributed the inability to pass costs through to a 15-day lag between order-taking and price adjustment. Fair diagnosis. But here's where credibility cracked: the company claims it can immediately pass on cost increases, yet just demonstrated it couldn't. A 15-day lag, repeated across thousands of orders, is a structural feature of the business model (agent-based, 50% from top 10 agents), not a one-time friction.
Due to the geopolitical tensions in the Middle East and US, there was a sharp increase in the crude oil prices, which resulted in significant volatility in our raw material, such as PTA and MEG.
The unsustainable story: volumes down 17%, sales up anyway
Production fell 17% quarter-on-quarter. Despite this, revenue was maintained. How? Inventory liquidation — the company drew down stock to keep sales numbers respectable. Management disclosed this directly: sales maintained via stock liquidation, not organic demand growth. This is a one-quarter trick. Inventory doesn't regenerate without production, so if demand truly weakened (or was merely flat), Q2-Q3 will show it in the P&L. The quarter gives no confidence that underlying apparel and home textile demand is strong, only that management prioritized reported revenue over honest inventory accounting.
Demand across apparel, home textile strong
PAT crashed 86% YoY; revenue growth only 9.6%
Contradicted
Able to pass on cost increases immediately
Gross margin fell 1000 bps; couldn't pass through costs despite 15-day order cycle
Overstated
Operating environment improving, stabilizing
Q1 margins collapsed to 0.4% NPM from prior ~3.5%
Overstated
Revenue growth healthy despite production down 17%
Sales maintained via stock liquidation, not organic demand growth
Supported (but unsustainable)
FY27 EBITDA 6%, PAT 3.5%-4%
Q1 delivered 3.24% EBITDA, 0.4% PAT; requires 8-10x quarterly improvement
Overstated
What changed on this call — balance sheet wins, profit recovery unproven
Sumeet successfully raised ₹199.75 Cr via rights issue and deployed it thoughtfully: ₹100 Cr to working capital (to reduce CC facility dependence), ₹50 Cr to Nakoda acquisition, ₹23 Cr to debt repayment (which happened immediately), and ₹22 Cr to solar capex. Gross debt falls from ₹160 Cr to a target of ~₹50 Cr by FY27 end. The 30 TPA capacity expansion came online in July-Aug (ahead of schedule). These are genuine wins on the balance sheet and strategic positioning. But they address the wrong problem for this quarter: debt and capacity, not profit margin recovery. The immediate challenge — restoring gross margins from 15% to 25%+ — remains unresolved.
Rights issue delivered on time (₹199.75 Cr) with strong shareholder participation
30 TPA capacity online ahead of schedule; 140K TPA Nakoda on track for Q2 FY28
Debt paydown ₹23 Cr already; path to ₹50 Cr gross debt by FY27 end credible
Value-added yarn mix expanding (30-35% now) — differentiator vs integrated players
Solar (6.5 MW) Q4 FY27 will save ₹25 Cr annually — material structural benefit
Profits collapsed 85.7% despite revenue up 9.6% — structural margin pressure
Gross margin fell 1000 bps to 15%; prior 25%+ target recovery mechanism unclear
Volume down 17% but revenue held via inventory liquidation — unsustainable
FY27 guidance (>30% revenue, 6% EBITDA, 3.5%-4% PAT) requires 8-10x profit lift with no Nakoda ramp
Prior 5% NIM target abandoned mid-course — guidance credibility damaged
Customer concentration (50% from 10 agents) limits pricing power
Nakoda (major catalyst) launches Q2 FY28, not FY27 — timing misaligned with guidance
Margin recovery unproven
HighGross margin fell to 15% vs 25%+ prior. Management couldn't pass costs despite claiming immediate adjustment. If cost inflation is structural (geopolitical, freight scarcity), recovery is constrained. Prior 5% NIM target abandoned; new 3.5%-4% is 130 bps lower.
FY27 guidance overstated
HighGuided >30% revenue, 6% EBITDA, 3.5%-4% PAT. Q1 delivered 9.6% revenue, 3.24% EBITDA, 0.4% PAT. Remaining 9 months need material acceleration and 8-10x profit recovery — without Nakoda (Q2 FY28).
Nakoda execution delay
HighNakoda (140K TPA, doubles capacity) positioned as major catalyst but delayed to Q2 FY28. Commissioning, ramp-up, customer offtake, integration unproven. Any delay cascades into FY28.
Customer concentration
Medium50% of revenue from top 10 agents (agent-based B2B model). Agent churn or consolidation could pressure volumes. Pricing power limited due to dependency.
Working capital cycle extension
Medium₹100 Cr WC deployment post-rights issue. If demand softens or cycle extends beyond 30-45 day norm, cash generation pressured and CC facility still needed.
Debt service burden
MediumGross debt ₹160 Cr pre-rights (₹86 LT + ₹74 ST). While ₹23 Cr repayment helps, finance cost is still a margin headwind masking weak operational profitability.
How the street is positioned — price action, ownership, the oversold signal
The market's verdict on Q1 was swift and severe. On day 1 post-result (Aug 5 announcement), the stock fell 4.97% from ₹19.13. By day 3, the decline extended to 14.17%, landing at ₹16.42. That move hasn't reversed — the stock now sits 59% below its all-time high of ₹40.5, and sits below its 20-day (+35%), 50-day (+40%), and 200-day (+44%) moving averages. RSI is at 0, signaling severe oversold conditions. Volume is declining. This is a market pricing extreme skepticism: both of the margin recovery thesis (Q1 proved it doesn't work) and of the FY27 guidance (8-10x profit improvement is not credible without Nakoda, which launches Q2 FY28).
Ownership reinforces this. Promoter shareholding fell from 89.83% (Q1 FY27) to 68.05% (Q2 FY27) — a 21.78 percentage-point dilution from the rights issue at ₹11.86/share. Post-issue, promoter ownership remains ~68%, a strong majority. However, FII and DII participation is near-zero (0.01% and 0.15% respectively). This is a promoter-held stock with no institutional interest. The price action suggests retail selling and pro-rata dilution, not institutional bargain-hunting at these levels. That's a market signal: at 59% below ATH and deeply oversold, even the marginal buyer is not convinced.
1 · Q2 gross margin trajectory
Did Q1's 15% margin hold, recover, or worsen? Cost stabilization is the prerequisite for FY27 guidance credibility. If margin stays below 18%, FY27 targets evaporate.
2 · Volume and organic revenue growth
Production volumes are the honest demand signal. If Q2 volumes stabilize and track with revenue, inventory draw is done and underlying demand is credible. If volumes stay down but revenue is again propped up, the margin recovery story worsens.
3 · 30 TPA ramp utilization by Q2 end
The 30 TPA capacity came online in July-Aug. By September (Q2 end), it should be ramping. Watch for unit contribution margin; if new capacity is under-utilised or at lower margins, it won't drive guidance.
4 · Nakoda commissioning timeline confirmations
Commissioning delays are the execution risk. Any slip beyond Q2 FY28 extends the period Sumeet runs at low margins and erodes FY28 guidance credibility.
Q1 was a quarter where revenue held up but profitability imploded. The company maintained sales by drawing inventory — a one-quarter fix — and guided for margin recovery on the strength of cost stabilization and upcoming capacity ramps. But it just proved it can't stabilize costs despite claiming immediate price pass-through, and major capacity (Nakoda) doesn't launch until Q2 FY28, after FY27 ends. The guided >30% revenue and 3.5%-4% PAT for full-year FY27 are aspirational, not earned.
For holders, the real stock is a multi-year bet on Nakoda execution and de-risking (the ₹195 Cr rights capital works). For traders, FY27 is a washout — margin recovery is unproven, Nakoda is too late, and guidance has already been cut (prior 5% NIM → current 3.5%-4% PAT). The stock is deeply oversold and owned entirely by promoters and retail. An institutional re-entry would signal belief in the Nakoda thesis, but that's a 2027-2028 story, not a Q2 FY27 one.
The single number to track from here: Q2 gross margin. If it stabilizes above 20%, management retains a path to FY27 guidance. If it re-compresses below 18%, FY27 targets evaporate and the stock extends lower.
Growth masks margin collapse; recovery unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 5/10
Grade B
Rights issue delivered on time (₹195Cr), Nakoda acquisition progressing, 30 TPA online. But prior 5% NIM target abandoned and major profit decline.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered 9.6% revenue growth but PAT collapsed 85.7%, signaling margin pressure. Management cites temporary crude volatility but couldn't pass costs through, suggesting structural weakness. FY27 guidance (3.5%-4% PAT) is aggressive vs prior 5% NIM target and Q1's 0.4% base.
₹272.4 Cr
Revenue · +9.6% YoY₹1.1 Cr
Reported PAT · −85.7% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Demand across apparel, home textile strong
MISSPAT crashed 86% YoY; revenue growth only 9.6%
Able to pass on cost increases immediately
OVERSTATEDGross margin fell to 15% from 25%+; couldn't fully pass through costs
Operating environment improving, stabilizing
OVERSTATEDQ1 margins collapsed to 0.4% NPM from prior ~3.5%
Revenue growth healthy despite production down 17%
METSales maintained via stock liquidation, not organic demand growth
FY27 EBITDA 6%, PAT 3.5%-4%
OVERSTATEDQ1 delivered 3.24% EBITDA, 0.4% PAT; requires 8-10x improvement
Earnings quality
What changed since the last call
Profitability collapsed
DowngradePAT fell to ₹1.1Cr (0.4% NPM) from prior ~₹7Cr (3%+ NPM). Prior 5% NIM target implicitly abandoned; guidance reset to 3.5%-4%.
Balance sheet strengthened
Upgrade₹195Cr net proceeds deployed: ₹100Cr working capital, ₹50Cr Nakoda, ₹23Cr debt repayment, ₹22Cr solar. Gross debt to fall from ₹160Cr to ~₹50Cr by FY27 end.
Capacity expansion progressing
Upgrade30 TPA commissioned in Q2 (July-Aug 2026). Nakoda 140K TPA on track for Q2 FY28. Total capacity to roughly double.
Product mix diversifying
NeutralValue-added yarn now 30%-35% of production (vs lower before). Margin benefit not yet visible given Q1 PAT collapse despite mix shift.
The Q&A
Himanshu Dugar pressed hard on gross margin recovery (25% guidance vs 15% Q1 actual); management cited volatility and 15-day order cycle but didn't provide clear recovery timeline. Analysts didn't challenge 30% revenue growth guidance despite Q1 showing only 9.6% YoY.
Production volumes — Himanshu Dugar, Stylus Holdings
AnsweredProduction down 17% QoQ due to volatile raw materials and 15-day maintenance. Sales maintained via stock liquidation; new capex to drive future volumes.
Debt position — Himanshu Dugar, Stylus Holdings
PartialLong-term ₹86Cr, short-term ₹74Cr (₹160Cr gross). After ₹23Cr repayment, target ~₹50Cr by FY27 end via debt pay-down and cash generation.
Renewable power savings — Riddhi Jain, Orient Capital
Partial₹25Cr annual savings when fully renewable. Gap driven by 30 TPA ramp, renewable power H2, demand recovery. Gross margins to exceed 25%+.
Value-added yarn mix — Riddhi Jain, Orient Capital
Answered30%-35% of yarn production is value-added. Nakoda to reach full capacity within 60 days of commissioning.
Revenue growth trajectory — Kurin, Tameda Realty
PartialFY27 revenue growth >30% vs FY26. Production increasing, prices sustaining. New capacity contributing.
EBITDA margin path — Kurin, Tameda Realty
PartialVery confident to achieve 6% EBITDA margin by end of FY27. New capacity, renewable power, and demand recovery will drive.
Nakoda commissioning status — Vidhi Purohit, Phoenix Capital
AnsweredNew machines ordered, restoration ongoing. Expect commissioning in next financial year, Q2 specifically. Full capacity within 60 days.
Gross margin recovery path — Himanshu Dugar, Stylus Holdings (follow-up)
DodgedConfident to achieve >25% gross margins. Q1 was volatile. Will maintain pricing discipline as raw material costs stabilize.
Customer concentration risk — Keval Gala, Gala Ventures
AnsweredB2B model uses agents (top 10 agents = ~50% revenue), end customers in thousands. Diversifying product range to serve new segments pan-India.
Debt trajectory post-rights — Keval Gala, Gala Ventures
PartialAfter ₹23Cr repayment, gross debt ~₹50Cr (was ₹83Cr). Machine term loan ~₹30-50Cr. Short-term CC to be minimal.
Guidance
FY27 >30% revenue growth YoY
LowQ1 delivered only 9.6% YoY; requires ~36% growth in Q2-Q4 to hit 30% full-year. Nakoda (major catalyst) launches Q2 FY28, too late to drive FY27.
EBITDA margin ~6% by FY27 end
LowQ1 delivered 3.24%. Requires ~90bps expansion per quarter. Depends on Nakoda, solar, demand recovery. Renewable power not fully online until Q4.
PAT margin 3.5%-4% for FY27
LowQ1 delivered 0.4%. Needs 8-10x improvement by year-end. Prior guidance was 5% NIM—this is a ~130bps cut.
~₹90Cr total capex (Nakoda ₹23.47Cr, solar ₹22Cr, other ₹44.5Cr)
HighFully funded by rights proceeds. Nakoda to launch Q2 FY28; solar Q4 FY27. Execution on track.
Risks the call surfaced
Margin recovery failure
HighGross margins fell to 15% (Q1) vs 25%+ prior. Management blamed inability to pass costs despite 15-day order cycle claim. If cost inflation is structural or competitive, margin recovery is unlikely.
Guidance credibility erosion
HighPrior guidance targeted 5% NIM increase by FY27. Q1 delivered 0.4% and new guidance is 3.5%-4%, a ~130bps cut. Management has lost credibility on margin targets; FY27 guidance appears aspirational.
Nakoda execution risk
HighNakoda CP plant (140K TPA) positioned as major growth driver but commissioning delayed to Q2 FY28 (6+ months away), missing FY27 contribution. Integration, ramp-up, customer offtake unproven.
Customer concentration
Medium50% of revenue from top 10 agents despite thousands of end customers. Agent churn or consolidation could pressure volumes. Pricing power limited if agents can switch.
Financing burden
MediumGross debt ₹160Cr pre-rights (₹86Cr LT + ₹74Cr ST). While rights issue provides relief, short-term working capital CC facility still in use. Finance cost is margin headwind; leverage limits strategic flexibility.
Management
Score 6/10. Clear on strategy (solar, Nakoda, value-added mix) but defensive on margin recovery. Some inconsistencies: renewable power % stated as 20% and 30% in different answers; debt numbers required clarification. Mixed: Rights issue delivered on time (₹195Cr), Nakoda acquisition progressing, 30 TPA commissioned early. But prior 5% NIM target abandoned after Q1 collapsed to 0.4%; credibility damaged.
1 · Q4 FY27
Solar power plant (6.5 MW) commissioning; ₹25Cr annual savings
2 · Q2 FY28
Nakoda CP plant commissioning; capacity doubles to 210K TPA
3 · Q1-Q3 FY28
Nakoda ramp-up to full utilization within 60 days of launch
FY27 guidance (3.5%-4% PAT) is aggressive vs prior 5% NIM target and Q1's 0.4% base.